West Pharma Struggles: Shares Dip Amid Dim 2024 Outlook
West Pharmaceutical Services experiences a significant drop in stock value due to a dim forecast for 2024, with lower sales ...
- Latest
- Trending
West Pharmaceutical Services experiences a significant drop in stock value due to a dim forecast for 2024, with lower sales ...
JFrog's Q4 FY2023 earnings surpassed expectations, with a 27.1% year-on-year revenue surge and increased profitability. The company also provided an ...
Akamai Technologies reported strong EPS but fell short on revenue for Q4 2023. Despite this, compute services revenue showed growth ...
Leidos Holdings has seen their price target increase by Stifel due to strong financial performance and positive market outlook, with ...
The travel industry is hoping for a "normal" 2024, but growth expectations are lower. Hilton, Marriott, and Expedia are forecasting ...
Leidos Holdings receives a price target upgrade from Stifel due to strong financial performance, exceeding earnings expectations. The company expects ...
Moody's Q4 earnings fell short on EPS but revenue exceeded expectations. Shares declined 4%. FY2024 guidance is lower than estimate, ...
Coca-Cola stock has been downgraded from "Strong Buy" to "Buy" by CFRA, with a revised price target of $66.00. Despite ...
Biogen shares experience a significant 5% drop in premarket trading following disappointing earnings report, but CEO remains optimistic about the ...
Marriott International exceeded analyst expectations with strong Q4 results, showcasing resilience in a challenging industry. EPS of $3.57 surpassed estimates ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.